Skip to main content
Clinical Trials/NCT05952180
NCT05952180CompletedNot Applicable

Effect of Virtual Reality Combined With Cycloergometer Versus Conventional Cycloergometer on Distance for ICU Non-sedated Participants: Prospective Randomized Controlled Trial

Centre Hospitalier Régional d'Orléans1 site in 1 country28 target enrollmentStarted: November 28, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
28
Locations
1
Primary Endpoint
Distance actively covered (in kilometers with one decimal)

Study Overview

Brief Summary

Management in intensive care unit (ICU) has gradually evolved to early mobilization. Studies have confirmed a 50% decrease impact on the functional abilities and quality of life after ICU. The cycloergometer is particularly studied and effective for early rehabilitation. Current practices encounter obstacles as fatigue, pain or a lack of motivation to mobilize. Several studies have been carried out to evaluate the effects of virtual reality (VR) on mental health and on cognitive abilities. To date, there is little evidence about VR on distraction and the impact on physical activity motivation in ICU.

The main hypothesis is that the use of combine cycloergometer and VR would improve the travelled distance by patients in ICU. Adverse effects would be observed initially in order to consolidate the safety data of this device. It would also allow a better participant experience.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Over 18 years old hospitalized in the surgical intensive care unit (USC or reanimation) of the Centre Hospitalier Régional d'Orléans
  • •Glasgow 15
  • •Satisfying the chair installation criteria before the inclusion
  • •With or without :
  • •any type of invasive or non-invasive ventilation
  • •any type of oxygenation
  • •Stable within its medically determined target parameters
  • •Hemodynamically stable (MAP>65)

Exclusion Criteria

  • •Person presenting a medical contraindication to cycloergometer
  • •Person under guardianship or curatorship
  • •Person under court protection
  • •Stay less than 48 hours (post-neurosurgery surveillance)
  • •Persons weighing over 180 kg
  • •Person not affiliated to a social security system
  • •Pregnant or breast-feeding Women
  • •Deaf and visually impaired people
  • •Patient included in another study with the same endpoint

Arms & Interventions

Virtual reality and Cycloergometer

Experimental

The session performed uses a standard cycloergometer, with the participant pedaling in a seated position with the lower limbs. A 43 inches TV screen is placed in front of the cycloergometer where the participant will watch a video of a walk through a natural environment on. The speed of the walk is linked to the pedaling speed so that the faster the participant pedals, the faster the video goes too. The session last 30 minutes in the participant's room.

Intervention: Virtual reality and Cycloergometer (Device)

Standard cycloergometer

Active Comparator

For the "standard cycloergometer" intervention, the session uses usual cycloergometer with the participant pedaling in a seated position with the lower limbs. No virtual reality is used. The session last 30 minutes in the participant's room

Intervention: Standard cycloergometer (Other)

Outcomes

Primary Outcomes

Distance actively covered (in kilometers with one decimal)

Time Frame: Day 2

Distance actively covered (in kilometers) with the combination of virtual reality and cycloergometer versus distance actively covered (in kilometers with one decimal) with conventional seated cycloergometer session

Secondary Outcomes

  • Number of adverse effects noted during the session(Day 2)
  • Measure of patient's experience with Visual Analogic Scale (on /10)(Day 2)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials